ABSTRACT The mechanism for the prolonged contractile dysfunction observed in myocardium reperfused after reversible regional ischemia ("stunned" myocardium) is unclear. Recent studies suggest that myocardial stunning may be mediated by oxygen-derived free radicals, but the precise molecular species involved remain unknown. Thus we explored the role of the highly cytotoxic hydroxyl radical in regional postischemic dysfunction by using dimethylthiourea (DMTU), an effective and highly permeable hydroxyl radical scavenger. Open-chest dogs undergoing a 15 min occlusion of the left anterior descending coronary artery followed by 4 hr of reperfusion received either DMTU (0. 5 g/kg iv over 45 min starting 30 min before occlusion, n = 14) or saline (n = 15). Control and treated dogs were comparable with respect to variables that may affect postischemic dysfunction, including heart rate, aortic pressure, left atrial pressure, arterial blood gases and hemoglobin concentration, size of the occluded bed (determined by postmortem perfusion), and collateral blood flow (determined by radioactive microspheres). Regional myocardial function was assessed by measuring wall thickening with an epicardial Doppler probe. The two groups exhibited comparable systolic thickening under baseline conditions and similar degrees of dyskinesis during ischemia. After reperfusion, however, wall thickening (expressed as percent of baseline) was considerably greater in treated as compared with control dogs: 53 + 9% (mean -+-SEM) vs 9 ± 14% (p < .03) at 1 hr, 55 ± 9% vs 23 ± 13% (p < .05) at2hr, 60 + 9% vs28 ± 14% (p< .05)at3hr,and67 ± 5%vs36 + 13% (p< .05)at4hr. Thus DMTU produced a significant and sustained improvement in recovery of contractile function. In concentrations greater than the plasma levels attained in vivo, DMTU did not scavenge either hydrogen peroxide or superoxide anion in vitro. These results suggest that the myocardial dysfunction occurring after a brief episode of regional ischemia is mediated in part by the hydroxyl radical. Circulation 76, No. 2, 458-468, 1987. MYOCARDIUM reperfused after a reversible ischemic insult exhibits prolonged contractile dysfunction ("stunned" myocardium).1-3 Despite considerable investigative efforts, the mechanism responsible for this phenomenon remains unclear. Recently, several studies have demonstrated that the recovery of the stunned myocardium is enhanced by agents that decrease the concentration of superoxide anion ( 02) and hydrogen
peroxide (H202), such as superoxide dismutase plus catalase 4-6 N-2-mercaptopropionylglycine, and allopurinol,5 suggesting that accumulation of 02 and/or H202 plays an important role in the genesis of postischemic dysfunction.
These studies4-1 did not attempt to discern the relative roles of the various oxygen species in myocardial stunning. Both *02 and H202 are theoretically capable of producing myocellular damage in themselves. In addition, '02 and H202 can react to generate the hydroxyl radical (.OH), an oxidant considerably more potent than either of its precursors.9' 10 Consequently, accumulation of 0°2 or H 0 could produce postischemic dysfunction either directly, via the cytotoxic actions of these species, or indirectly, via * OH generation. Administration of an * OH scavenger may help discern between these two mechanisms because it would not interfere with injury caused directly by '02 or H202 but it should attenuate the toxic actions of CIRCULATION *OH. To date, no data are available regarding the potential contribution of OH to regional myocardial stunning in the intact animal. Such information would not only help to elucidate the mechanisms of radicalmediated damage but may also have therapeutic implications.
Evaluation of the role of OH in tissue injury has been hindered by the fact that there are no known enzymatic scavengers of this radical and the chemical scavengers available (e.g., dimethyl sulfoxide, mannitol, ethanol) may lack potency or specificity.11 Recently, Fox et al." ' 12 have described the *OH-scavenging properties of dimethylthiourea (DMTU), a compound that is more effective than traditional * OH scavengers and is highly cell permeable. We therefore used DMTU as a probe to explore the role of the OH radical in postischemic dysfunction. We employed a previously described4'71 8, 13 open-chest canine preparation in which severe myocardial stunning is produced by a 15 min coronary occlusion followed by reperfusion. This duration of ischemia was selected because it is well established that it does not result in myocardial necrosis in the dog,2' 14, 15 although it does produce prolonged depression of contractility.1 2, 4, 13 In addition, studies in vitro were performed to (1) elucidate the specificity of DMTU for *OH, (2) correlate the plasma DMTU levels attained in vivo with the effective OH-scavenging concentrations in vitro, and (3) determine the pharmacokinetics of DMTU.
Methods
This study was performed in accordance with the guidelines of the Committee on Animals of Baylor College of Medicine and with the "Guiding Principles in the Use and Care of Animals" approved by the American Physiological Society.
Measurement of oxygen metabolites in vitro. Previous studies" have shown that DMTU is an effective scavenger of *OH. We carried out additional experiments in vitro at the Medical College of Virginia to determine the specificity of DMTU; to this end, the ability of various concentrations of DMTU to scavenge 02 and H202 was evaluated.
Superoxide generated as a result of xanthine oxidase (0.02 U/ml) action on xanthine (53 ,M) was monitored by reduction of ferricytochrome c (22 ,uM, Type VI, Sigma Chemical Co.) at a wavelength of 550 nm in the presence or absence of superoxide dismutase (10 gg/ml). DMTU (1 to 10 mM) was included in the reaction mixture to determine its ability to scavenge O°2 .
Hydrogen peroxide was produced in vitro by the action of glucose oxidase (0.15 U/mi) on glucose (3.6 mM). The rate of H202 production in the reaction mixture was determined by monitoring the absorption at 505 nm during its oxidative coupling with 4-aminoantipyrine and phenol to yield quinoeimine dye. The difference in the change of absorbance during the production of quinoeimine dye in the presence and absence of catalase (100,ug/ml) was considered as a conservative estimate of the rate of H202 production. DMTU (1 to 10 mM) was included in the reaction mixture to determine its ability to scavenge H202. Dupont Co.) were obtained as 1 mCi of nuclide suspended in 10 ml of 10% dextran with 0.01% Tween 80 to minimize clumping. Microspheres were labeled with 95Nb or '41Ce. Before injection, the vial containing microspheres was vigorously agitated on a mechanical mixer for 2 min. Approximately 1.5 million spheres were then injected into the left atrium in 3 ml of normal saline over 10 to 15 sec; the catheter was flushed with an additional 10 ml of saline. Beginning 15 sec before and continuing for 2 min after the end of the injection, blood was withdrawn from the aorta with a Harvard pump at a constant rate of 4.05 ml/min. After postmortem perfusion and TTC staining, four transmural samples (1.0 to 1.5 g) were obtained from both the occluded and nonoccluded beds. Each specimen was divided into epicardial and endocardial halves and weighed. To avoid admixture of ischemic and nonischemic tissue, ischemic samples were obtained at least 1 cm inside the margin of the unstained region. The radioactivity of the tissue and reference blood samples was determined with a sodium iodide crystal well counter. Regional myocardial blood flow was calculated by standard methods as previously described. '8 Regional myocardial function. Regional myocardial function was assessed with a pulsed Doppler epicardial wall thickening probe, as previously described.4 7 8. 13 Theoretical and experimental validation of this technique has been published elsewhere. 17, 22 In brief, the pulsed Doppler technique uses a single epicardial transducer to determine systolic myocardial wall displacement by digitally integrating the velocity of myocardial layers passing through the range-gated sample volume. Representative examples of the tracings obtained with this probe are shown in figure 1 .
The beginning and end of systole were determined from the onset of the rapid upstroke of the left ventricular pressure tracing and the peak negative dP/dt, respectively. Systolic thickening fraction was calculated by dividing net systolic thickening by end-diastolic wall thickness as determined by the range gate depth.22 Net systolic thickening was defined as the maximal systolic increase in wall thickness from the end-diastolic value.4 When paradoxical wall thinning persisted for 50% or more of systole, the maximal extent of wall thinning was subtracted from wall thickening to give net systolic thickening.4 Because wall thickening can vary markedly with the respiratory cycle, all measurements were taken at end-expiration. At Measurement of DMTU concentration. DMTU concentration was measured by gas chromatography23 at the University of Colorado Health Sciences Center. An internal standard was made by dissolving diethyl sulfone (3.5 g) (ICN Pharmaceutical, Inc., Plainville, NY) in deionized water (100 ml) in a volumetric flask. The solution was then filtered through a Whatman No. 2 filter and stored at room temperature. An aliquot of this solution (1%) was added to a 1 ml test sample. The test sample was then treated with perchloric acid (1 .8M) to precipitate the protein (200 ,ul perchloric acid/ml sample). Each sample was vortexed and placed on ice for 10 min, then centrifuged at 500 g for 5 min. To the supernatant was added 2M K2HPO4 (200 pul). The sample was vortexed, placed on ice for 5 min, and centrifuged at 500 g for 5 min. One microliter of the supernatant was injected into the gas chromatograph. DMTU concentration was assessed with a Varian gas chromatograph (Model 3700) equipped with an FID detector and a Varian 4270 integrator.
The 2 ft long, 1/4 inch od x 2 mm id glass column was packed with 20% Carbowax 20M on Supelcoport, 80/100 mesh (Supelco, Bellfonte, VA). Operating conditions were: injector temperature 2600C, oven temperature initially 1200 C for 2 min, temperature program 30°C/min to 1550 C for 4 min. Helium, hydrogen, and air flows were set at 30, 30, and 300 ml/min, respectively. The integrator was programmed to integrate and print out peak area and retention time. The peak area for DMTU was divided by the peak area for the internal standard to give a peak area ratio for each injection. 
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1T:.-.1: 45 and 60 min after start of infusion (interval corresponding to the first few minutes of coronary reperfusion in the experimental group). DMTU plasma concentrations then declined slowly, and 4 hr after discontinuing the infusion (i.e., at the time when the dogs in the experimental group were killed) they still exceeded 4 mM. These data demonstrate that the dosage in this study resulted in relatively steady DMTU plasma levels that were equal to or greater than the concentrations that effectively scavenge *OH in vitro (5 mM"').
Pharmacokinetics of DMTU. The pharmacokinetic variables of DMTU in the dog are unknown. Because this information would be important in the design of future studies, additional experiments were conducted to determine the elimination half-life and volume of distribution of this agent. In the two conscious dogs in which DMTU plasma levels were measured for 96 hr after administration of a 500 mg/kg bolus, the elimination half-life of DMTU was found to be 28.7 and 33.7 hr, respectively, and the volume of distribution at steady state 1.09 and 1.53 liters/kg, respectively. The large volume of distribution provides further evidence for the ability of DMTU to penetrate the interstitial and intracellular compartments.
Exclusions. Of the 51 dogs initially anesthetized for the recovery of function protocol, four were not used because of hypoxemia (Pao2 < 65 mm Hg) and two because of severe anemia (hemoglobin concentration < 7 g/dl). Four animals (two from each group) were excluded because of high collateral flow to the ischemic region (0.32 and 0.61 ml/minlg in the control and 0.33 and 0.57 ml/min/g in the treated dogs). Although these animals with mild ischemia exhibited dyskinesis 5 min after coronary occlusion, they showed little or no myocardial stunning; that is, contractile function 462 returned to values similar to preocclusion levels within 1 hr of reperfusion (at 1 hr, thickening fraction, expressed as percent of preocclusion, was 80% and 93%, respectively, in the control dogs, and 80% and 85%, respectively, in the treated dogs). These data are consistent with our previous observations2' that collateral flow is a major determinant of the recovery of function after reperfusion, and emphasize the importance of measuring blood flow to the ischemic zone when investigating myocardial stunning. Two dogs (one in the control and one in the treated group) died of ventricular fibrillation during ischemia, and 10 died of ventricular fibrillation immediately after reperfusion (seven in the control and three in the treated group). Thus analysis of data was carried out in 15 control and 14 treated dogs.
Arterial blood gases and hemoglobin. Particular care was taken to ensure that acid-base balance and tissue oxygenation were adequate in every dog admitted to the study. As a result, arterial blood pH, Po2, and hemoglobin concentrations were within normal limits in all control and treated animals. Thirty minutes before coronary artery occlusion, the following measurements were obtained in the control and treated groups, respectively: arterial pH, 7.42 ± 0.01 and 7.43 ± 0.01; arterial Po2, 87 ± 4 and 87 4 mm Hg; arterial hemoglobin concentration, 12.0 ± 0.4 and 12.9 ± 0.4 g/dl. Arterial blood gases were monitored during the rest of the experiment and were kept within normal limits (pH 7.36 to 7.44; Po2> 65 mm Hg) by adjusting ventilatory variables.
Systemic hemodynamics. In the treated group, measurements were obtained before and 25 min after start of DMTU infusion (i.e., 5 min before coronary occlusion [preocclusion values]). In the control group, preocclusion measurements were taken 5 min before coronary occlusion. Infusion of DMTU did not appreciably affect any of the measured hemodynamic variables (table 2). As shown in figure 2, there were no significant differences between control and treated groups with respect to preocclusion heart rate, mean arterial blood pressure, or peak positive left ventricular dP/dt. Preocclusion mean left atrial pressure was slightly lower in the treated group compared with the control group (4.7 ± 0.3 vs 6.6 ± 0.5 mm Hg; p < .05), but this difference became insignificant at subsequent time points. No significant hemodynamic difference developed between the two groups throughout the course of the study except for a modest decline in left atrial pressure at 4 hr of reperfusion in treated compared with control dogs (3.8 ± 0.1 vs 6.3 ± 1.0 mm Hg; p < .05) (figure 2). There were no significant differences between control and treated dogs.
ARatio of transmural ischemic zone flow to simultaneous transmural nonischemic zone flow.
Representative examples of the time course of recovery of contractile function in the two groups are illustrated in figure 1 .
Histochemical analysis. TTC staining confirmed the absence of infarction in all animals. This finding is consistent with previous studies2' 14, 15 showing that the myocardial injury associated with a 15 min coronary occlusion in the dog is completely reversible.
Discussion
This study demonstrates that DMTU produces a sustained improvement in recovery of myocardial function after regional reversible ischemia. After 1 hr of reperfusion, the previously ischemic myocardium had recovered approximately half of its baseline systolic function in dogs treated with DMTU but was still essentially akinetic in control animals. Over the ensuing 3 hr, the performance of the stunned myocardium in the treated group remained at a level approximately twice that of the control group. These results implicate *OH (or a secondary radical derived from it) in the pathogenesis of regional postischemic dysfunction. Although other studies have suggested that * OH may contribute to the dysfunction that follows prolonged global ischemia in the arrested heart perfused with artificial solutions,2F26 no previous investigation has suggested a role of the * OH radical in the myocardial stunning observed in the working, blood-perfused heart after brief, reversible regional ischemia. AThe preocclusion values reported for the treated group are the measurements taken 5 min before coronary occlusion, i.e., 25 min after start of DMTU infusion. These values were not different from those obtained under baseline conditions before treatment (table 1) .
Mechanism of the beneficial effects of DMTU. A detailed analysis was carried out to exclude nonspecific effects unrelated to the * OH-scavenging properties of DMTU. Several variables that might influence postischemic dysfunction were examined, but no differences were found between control and treated animals that could account for the observed enhancement in recovery of contractility. The two groups were quite similar with respect to arterial pH, Po2 and hemoglobin concentration, occluded bed size, collateral flow, and systemic hemodynamics. Left atrial pressure was slightly lower in treated dogs at 4 hr of reperfusion, but this factor, if anything, would be expected to reduce wall thickening by reducing preload.
It is unlikely that the attenuation of stunning by DMTU was related to removal of°2 or H202 because in our experiments in vitro using the xanthine-xanthine oxidase reaction to generate *°2 and the glucose oxidase reaction to generate H202, no scavenging action on either oxygen metabolite was observed even with concentrations of DMTU (10 mM) that exceeded those achieved in the plasma in our dogs (5 to 9 mM). This conclusion is further supported by previous studies in vitro using different assays,'1 in which 10 mM DMTU failed to affect 0°2 production by neutrophils and reacted only very slowly with H202 (estimated rate constant ' 0.1 M-'sec-'). DMTU has also been reported to react with H202 in other systems,27 but because of the extremely low rate constant it is unlikely that removal of H202 is a major mechanism for the protective effects of this agent. It should also be pointed out that there are reasons to suspect that the damage caused by H202 is mediated primarily by its conversion to -OH via the Fenton reaction.9 For example, it has been demonstrated that the ability of H202 to damage bacteria28' 29 DMTU has been shown to protect against a number of pathologic processes mediated by reactive oxygen metabolites, including pulmonary edema induced by activated neutrophils"' 27 or by an 02-generating system (purine-xanthine oxidase),57 pulmonary oxygen toxicity," and radiation mortality.'2 Since *OH is the principal oxidizing radical generated by ionizing radiation,56 protection against radiation provides strong evidence for an * OH-scavenging action of DMTU in vivo. The present study is the first to use DMTU in the setting of myocardial ischemia. Because of the beneficial effect on postischemic dysfunction, the favorable pharmacokinetic properties, the absence of appreciable hemodynamic actions at this dosage, and the other properties described above, DMTU appears to be a useful probe for assessing the role of * OH in experi- 
